Literature DB >> 14677893

Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis.

O Y Gonzalez1, G Adams, L D Teeter, T T Bui, J M Musser, E A Graviss.   

Abstract

BACKGROUND: The increases in extra-pulmonary tuberculosis (EPTB) have been largely due to human immunodeficiency virus co-infection. The rates of EPTB have remained constant despite the decline in pulmonary tuberculosis (PTB) cases.
OBJECTIVE: To evaluate covariates associated with EPTB.
METHODS: A 4-year cohort of EPTB patients was compared with PTB cases. Enrollees were assessed for TB risk, medical records were reviewed, and Mycobacterium tuberculosis isolates were fingerprinted.
RESULTS: We identified 538 EPTB cases (28.6%) in a total of 1878 enrollees. The most common sites of infection were lymph nodes (43%) and pleura (23%). EPTB cases included 320 (59%) males, 382 (71%) patients were culture-positive, and 332 (86.9%) patient isolates were fingerprinted. Fewer EPTB than PTB patients belonged to clustered M. tuberculosis strains (58% vs. 65%; P = 0.02). A multivariate model identified an increased risk for EPTB among African Americans (OR = 1.9, P = 0.01), HIV-seropositive (OR = 3.1, P < 0.01), liver cirrhosis (OR = 2.3, P = 0.02), and age <18 years (OR = 2.0, P = 0.04). Patients with concomitant pulmonary and extra-pulmonary infections were more likely to die within 6 months of TB diagnosis (OR = 2.3, P < 0.01).
CONCLUSIONS: African American ethnicity is an independent risk factor for EPTB. Mortality at 6 months is partly due to the dissemination of M. tuberculosis and the severity of the underlying co-morbidity.

Entities:  

Mesh:

Year:  2003        PMID: 14677893

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  37 in total

1.  Immunohistological characterization of spinal TB granulomas from HIV-negative and -positive patients.

Authors:  S Danaviah; J A Sacks; K P S Kumar; L M Taylor; D A Fallows; T Naicker; T Ndung'u; S Govender; G Kaplan
Journal:  Tuberculosis (Edinb)       Date:  2013-03-28       Impact factor: 3.131

2.  High proportion of extrapulmonary tuberculosis in a low prevalence setting: a retrospective cohort study.

Authors:  J N Sama; N Chida; R M Polan; J Nuzzo; K Page; M Shah
Journal:  Public Health       Date:  2016-04-29       Impact factor: 2.427

3.  The burden and treatment outcomes of extra-pulmonary tuberculosis in Bhutan.

Authors:  T Jamtsho; A D Harries; S Malhotra; D Wangchuk; U Dophu; T Dorji; T Dendup
Journal:  Public Health Action       Date:  2013-03-21

4.  Clinical relevance of Mycobacterium tuberculosis plcD gene mutations.

Authors:  Zhenhua Yang; Dong Yang; Ying Kong; Lixin Zhang; Carl F Marrs; Betsy Foxman; Joseph H Bates; Frank Wilson; M Donald Cave
Journal:  Am J Respir Crit Care Med       Date:  2005-04-01       Impact factor: 21.405

5.  High rates of tuberculosis in patients accessing HAART in rural South Africa.

Authors:  Kogieleum Naidoo; Quarraisha Abdool Karim; Ambika Bhushan; Kasavan Naidoo; Nonhlanhla Yende-Zuma; Patricia K McHunu; Janet Frohlich; Farina Karim; Michele Upfold; Paul Kocheleff; Salim S Abdool Karim
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

Review 6.  Association of HIV infection with extrapulmonary tuberculosis: a systematic review.

Authors:  Rupak Shivakoti; Davina Sharma; Kiemanh Pham; Gabeena Mamoon
Journal:  Infection       Date:  2016-11-09       Impact factor: 3.553

7.  Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosis.

Authors:  Alison A Motsinger-Reif; Paulo R Z Antas; Noffisat O Oki; Shawn Levy; Steven M Holland; Timothy R Sterling
Journal:  BMC Med Genet       Date:  2010-03-02       Impact factor: 2.103

Review 8.  Antitubercular therapy in patients with cirrhosis: challenges and options.

Authors:  Naveen Kumar; Chandan Kumar Kedarisetty; Sachin Kumar; Vikas Khillan; Shiv Kumar Sarin
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

9.  Extrapulmonary tuberculosis in non-human immunodeficiency virus-infected adults in an endemic region.

Authors:  Mustafa Kürşat Ozvaran; Reha Baran; Meltem Tor; Ilknur Dilek; Dilay Demiryontar; Sibel Arinç; Nil Toker; Efsun Uğur Chousein; Ozlem Soğukpinar
Journal:  Ann Thorac Med       Date:  2007-07       Impact factor: 2.219

10.  Black race, sex, and extrapulmonary tuberculosis risk: an observational study.

Authors:  Christina T Fiske; Marie R Griffin; Holt Erin; Jon Warkentin; Kaltenbach Lisa; Patrick G Arbogast; Timothy R Sterling
Journal:  BMC Infect Dis       Date:  2010-01-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.